<p>尽管已经有了强劲的表现，<strong>Vita Coco Company, Inc.</strong>（纳斯达克代码：COCO）的股票仍在持续上涨，过去三十天上涨了 25%。回顾更长的时间段，令人鼓舞的是，过去一年该股票上涨了 50%。</p>
<p>在价格大幅反弹后，考虑到美国近一半的公司市盈率（或称&#34;P/E&#34;）低于 18 倍，你可能会考虑完全避免投资 Vita Coco Company，因为其市盈率为 44 倍。不过，仅仅根据市盈率来判断并不明智，因为可能有解释其如此高的原因。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>Vita Coco Company 的盈利增长优于最近大多数其他公司，表现相对良好。市盈率之所以可能较高，是因为投资者认为这种强劲的盈利表现将会持续。如果不是，那么现有股东可能会对股价的可持续性感到有些紧张。</p>
<p>查看我们对 Vita Coco Company 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784"/></p>
<p>纳斯达克 GS:COCO 市盈率与行业比较 2025 年 11 月 30 日</p>
<p>想知道分析师如何看待 Vita Coco Company 的未来与行业的对比吗？在这种情况下，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
<h2>增长指标告诉我们关于高市盈率的什么？</h2>
<p>为了证明其市盈率的合理性，Vita Coco Company 需要产生远超市场的卓越增长。</p>
<p>如果我们回顾过去一年的盈利增长，公司实现了 16% 的显著增长。最近三年期间，EPS 也实现了 835% 的整体增长，这得益于其短期表现。因此，股东们可能会欢迎这些中期的盈利增长率。</p>
<p>展望未来，十位分析师预计未来三年每年将实现 19% 的增长。市场预计每年仅能提供 11% 的增长，因此公司有望实现更强劲的盈利结果。</p>
<p>根据这些信息，我们可以看到为什么 Vita Coco Company 的市盈率相较于市场如此之高。显然，股东们不愿意抛售可能瞄准更繁荣未来的股票。</p>
<h2>最后总结</h2>
<p>Vita Coco Company 的市盈率像其股票在过去一个月一样高涨。我们认为市盈率的作用主要不是作为估值工具，而是用来衡量当前投资者情绪和未来预期。</p>
<p>正如我们所怀疑的，我们对 Vita Coco Company 的分析师预测的审查显示，其优越的盈利前景正在推动其高市盈率。在这种情况下，投资者认为盈利恶化的潜力不足以证明降低市盈率的合理性。在这种情况下，很难看到股价在近期内大幅下跌。</p>
<p>公司的资产负债表中可能存在许多潜在风险。查看我们对 Vita Coco Company 的 <strong>免费</strong> 资产负债表分析，其中包含对一些关键因素的六项简单检查。</p>
<p>你可能会找到比 Vita Coco Company 更好的投资。如果你想要一些可能的候选者，请查看这份 <strong>免费</strong> 的低市盈率且已证明能够增长盈利的有趣公司名单。</p>

COCO

<p>Vita Coco 公司（NASDAQ:COCO）的股票在过去一个月上涨了 25%，在过去一年上涨了 50%。尽管其市盈率高达 44 倍，超过市场平均水平，但公司强劲的盈利增长和积极的未来展望证明了这一估值是合理的。分析师预测未来三年年均增长率将达到 19%，超过市场的 11% 预测。投资者对公司的未来保持乐观，这也推动了其高市盈率</p>

<p>Despite an already strong run, <strong>The Vita Coco Company, Inc.</strong> (NASDAQ:COCO) shares have been powering on, with a gain of 25% in the last thirty days. Looking back a bit further, it's encouraging to see the stock is up 50% in the last year.</p>
<div class="lb-trans"><p>尽管已经有了强劲的表现，<strong>Vita Coco Company, Inc.</strong>（纳斯达克代码：COCO）的股票仍在持续上涨，过去三十天上涨了 25%。回顾更长的时间段，令人鼓舞的是，过去一年该股票上涨了 50%。</p>
</div><p>Following the firm bounce in price, given close to half the companies in the United States have price-to-earnings ratios (or &#34;P/E's&#34;) below 18x, you may consider Vita Coco Company as a stock to avoid entirely with its 44x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>在价格大幅反弹后，考虑到美国近一半的公司市盈率（或称&#34;P/E&#34;）低于 18 倍，你可能会考虑完全避免投资 Vita Coco Company，因为其市盈率为 44 倍。不过，仅仅根据市盈率来判断并不明智，因为可能有解释其如此高的原因。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>With earnings growth that's superior to most other companies of late, Vita Coco Company has been doing relatively well. The P/E is probably high because investors think this strong earnings performance will continue. If not, then existing shareholders might be a little nervous about the viability of the share price.</p>
<div class="lb-trans"><p>Vita Coco Company 的盈利增长优于最近大多数其他公司，表现相对良好。市盈率之所以可能较高，是因为投资者认为这种强劲的盈利表现将会持续。如果不是，那么现有股东可能会对股价的可持续性感到有些紧张。</p>
</div><p>See our latest analysis for Vita Coco Company</p>
<div class="lb-trans"><p>查看我们对 Vita Coco Company 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784" alt="" original-src="https://images.simplywall.st/asset/chart/29328309-pe-multiple-vs-industry-1-dark-2/1764505189784"/></p>
<p>NasdaqGS:COCO Price to Earnings Ratio vs Industry November 30th 2025</p>
<div class="lb-trans"><p>纳斯达克 GS:COCO 市盈率与行业比较 2025 年 11 月 30 日</p>
</div><p>Keen to find out how analysts think Vita Coco Company's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析师如何看待 Vita Coco Company 的未来与行业的对比吗？在这种情况下，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
</div><h2>What Are Growth Metrics Telling Us About The High P/E?</h2>
<div class="lb-trans"><h2>增长指标告诉我们关于高市盈率的什么？</h2>
</div><p>In order to justify its P/E ratio, Vita Coco Company would need to produce outstanding growth well in excess of the market.</p>
<div class="lb-trans"><p>为了证明其市盈率的合理性，Vita Coco Company 需要产生远超市场的卓越增长。</p>
</div><p>If we review the last year of earnings growth, the company posted a terrific increase of 16%. The latest three year period has also seen an excellent 835% overall rise in EPS, aided by its short-term performance. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.</p>
<div class="lb-trans"><p>如果我们回顾过去一年的盈利增长，公司实现了 16% 的显著增长。最近三年期间，EPS 也实现了 835% 的整体增长，这得益于其短期表现。因此，股东们可能会欢迎这些中期的盈利增长率。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 19% per year as estimated by the ten analysts watching the company. With the market only predicted to deliver 11% each year, the company is positioned for a stronger earnings result.</p>
<div class="lb-trans"><p>展望未来，十位分析师预计未来三年每年将实现 19% 的增长。市场预计每年仅能提供 11% 的增长，因此公司有望实现更强劲的盈利结果。</p>
</div><p>With this information, we can see why Vita Coco Company is trading at such a high P/E compared to the market. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.</p>
<div class="lb-trans"><p>根据这些信息，我们可以看到为什么 Vita Coco Company 的市盈率相较于市场如此之高。显然，股东们不愿意抛售可能瞄准更繁荣未来的股票。</p>
</div><h2>The Final Word</h2>
<div class="lb-trans"><h2>最后总结</h2>
</div><p>Vita Coco Company's P/E is flying high just like its stock has during the last month. We'd say the price-to-earnings ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.</p>
<div class="lb-trans"><p>Vita Coco Company 的市盈率像其股票在过去一个月一样高涨。我们认为市盈率的作用主要不是作为估值工具，而是用来衡量当前投资者情绪和未来预期。</p>
</div><p>As we suspected, our examination of Vita Coco Company's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. It's hard to see the share price falling strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>正如我们所怀疑的，我们对 Vita Coco Company 的分析师预测的审查显示，其优越的盈利前景正在推动其高市盈率。在这种情况下，投资者认为盈利恶化的潜力不足以证明降低市盈率的合理性。在这种情况下，很难看到股价在近期内大幅下跌。</p>
</div><p>A lot of potential risks can sit within a company's balance sheet. Take a look at our <strong>free</strong> balance sheet analysis for Vita Coco Company with six simple checks on some of these key factors.</p>
<div class="lb-trans"><p>公司的资产负债表中可能存在许多潜在风险。查看我们对 Vita Coco Company 的 <strong>免费</strong> 资产负债表分析，其中包含对一些关键因素的六项简单检查。</p>
</div><p>You might be able to find a better investment than Vita Coco Company. If you want a selection of possible candidates, check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>你可能会找到比 Vita Coco Company 更好的投资。如果你想要一些可能的候选者，请查看这份 <strong>免费</strong> 的低市盈率且已证明能够增长盈利的有趣公司名单。</p>
</div>

Vita Coco 公司（纳斯达克股票代码：COCO）的股价上涨了 25%，但其市盈率仍然看起来合理